Stakeholder Feedback

Healthcare leaders' views

The Pharmaceutical Alliance fulfills a unique role in the healthcare sector and is supported by senior thought leaders:

"The lessons of the Integrated Care Program are likely to have a major influence on future programs to support clinical care in Australia for years to come."

- Enrico Coiera, Professor and Foundation Chair in Medical Informatics, University of NSW

"The Pharmaceutical Alliance are the innovators of the pharmaceutical industry in Australia. Whenever there are new ideas to collaborate around medicines in Australia, The Pharmaceutical Alliance are there."

- Dr John Aloizos, AM, Chair of Australian Pharmaceutical Advisory Council (APAC)

"It is reassuring to see good, outcomes-orientated projects to enhance quality use of medicines undertaken by a collaboration of stakeholders. I congratulate The Pharmaceutical Alliance for its vision and enthusiasm for exploring innovative initiatives based on partnerships and behaviour change. It is vital that pharmaceutical industry involvement in the achievement of quality use of medicines is supported and that activities can be discussed and refined based on the transparent nature of the work and the wide dissemination of the results."

- Ric Day, Professor of Clinical Pharmacology, University of Sydney, and Director of Clinical Pharmacology & Toxicology, St Vincent’s Hospital, Sydney

"The Pharmaceutical Alliance has actively worked with Divisions of General Practice and the government on programs to support quality use of medicines objectives. For example, The Pharmaceutical Alliance were key partners in the DiNCQUMGP cross-divisional project, designing and testing a method for GPs to do medication reviews for their elderly patients. They have built trust by providing non-product related support."

- Andrea Mant, Associate Professor School of Public Health & Community Medicine, University of New South Wales, Sydney